Jump to main content
Jump to site search

Issue 5, 2011
Previous Article Next Article

Molecular obesity, potency and other addictions in drug discovery

Author affiliations

Abstract

Despite the increase in global biology and chemistry knowledge the discovery of effective and safe new drugs seems to become harder rather than easier. Some of this challenge is due to increasing demands for safety and novelty, but some of the risk involved in this should be controllable if we had more effectively learnt from our failures. This perspective reflects on some of the learnings of recent years in relation to the causes of attrition. The term Molecular Obesity is introduced to describe our tendency to build potency into molecules by the inappropriate use of lipophilicity which leads to the premature demise of drug candidates.

Graphical abstract: Molecular obesity, potency and other addictions in drug discovery

Back to tab navigation

Article information


Submitted
18 Jan 2011
Accepted
14 Feb 2011
First published
07 Mar 2011

, 2011,2, 349-355
Article type
Review Article

Molecular obesity, potency and other addictions in drug discovery

M. M. Hann, , 2011, 2, 349
DOI: 10.1039/C1MD00017A

Search articles by author

Spotlight

Advertisements